Thomas Bais , Charlotte C.E.T. Pape , Loes Elferink , Karin G.F. Gerritsen , Tineke Kraaij , Ron T. Gansevoort , Martijn J. de Groot , Esther Meijer
{"title":"常染色体显性多囊肾病和Alport综合征的肾囊肿:两个说明诊断挑战的家族病例。","authors":"Thomas Bais , Charlotte C.E.T. Pape , Loes Elferink , Karin G.F. Gerritsen , Tineke Kraaij , Ron T. Gansevoort , Martijn J. de Groot , Esther Meijer","doi":"10.1053/j.ajkd.2025.04.022","DOIUrl":null,"url":null,"abstract":"<div><div>Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder and leads to the formation of kidney cysts, kidney enlargement, and kidney failure. We present a male patient initially misdiagnosed with ADPKD, partly based on his family history, who was later diagnosed with digenic Alport syndrome caused by pathogenic variants in <em>COL4A4</em> and <em>COL4A5</em>. Digenic Alport syndrome was subsequently diagnosed in 3 of his sisters, one of whom had previously been diagnosed with ADPKD, due to a de novo heterozygous pathogenic variant in <em>PKD1</em>. She had experienced an unusual clinical course for a patient with ADPKD, with remarkably rapid kidney function decline, persistent microscopic hematuria, and overt proteinuria. Through these cases, we aim to highlight alternative genetic causes of kidney cysts beyond ADPKD, describe how the phenotypical features in these cases were not fully explained by their known genotypes (leading to alternative or additional genetic diagnoses), and illustrate the importance of accurate genetic diagnoses for cascade screening.</div></div>","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"86 4","pages":"Pages 570-574"},"PeriodicalIF":8.2000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Kidney Cysts in Autosomal Dominant Polycystic Kidney Disease and Alport Syndrome: Two Familial Cases Illustrating Diagnostic Challenges\",\"authors\":\"Thomas Bais , Charlotte C.E.T. Pape , Loes Elferink , Karin G.F. Gerritsen , Tineke Kraaij , Ron T. Gansevoort , Martijn J. de Groot , Esther Meijer\",\"doi\":\"10.1053/j.ajkd.2025.04.022\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder and leads to the formation of kidney cysts, kidney enlargement, and kidney failure. We present a male patient initially misdiagnosed with ADPKD, partly based on his family history, who was later diagnosed with digenic Alport syndrome caused by pathogenic variants in <em>COL4A4</em> and <em>COL4A5</em>. Digenic Alport syndrome was subsequently diagnosed in 3 of his sisters, one of whom had previously been diagnosed with ADPKD, due to a de novo heterozygous pathogenic variant in <em>PKD1</em>. She had experienced an unusual clinical course for a patient with ADPKD, with remarkably rapid kidney function decline, persistent microscopic hematuria, and overt proteinuria. Through these cases, we aim to highlight alternative genetic causes of kidney cysts beyond ADPKD, describe how the phenotypical features in these cases were not fully explained by their known genotypes (leading to alternative or additional genetic diagnoses), and illustrate the importance of accurate genetic diagnoses for cascade screening.</div></div>\",\"PeriodicalId\":7419,\"journal\":{\"name\":\"American Journal of Kidney Diseases\",\"volume\":\"86 4\",\"pages\":\"Pages 570-574\"},\"PeriodicalIF\":8.2000,\"publicationDate\":\"2025-07-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Kidney Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0272638625009357\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Kidney Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0272638625009357","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
Kidney Cysts in Autosomal Dominant Polycystic Kidney Disease and Alport Syndrome: Two Familial Cases Illustrating Diagnostic Challenges
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder and leads to the formation of kidney cysts, kidney enlargement, and kidney failure. We present a male patient initially misdiagnosed with ADPKD, partly based on his family history, who was later diagnosed with digenic Alport syndrome caused by pathogenic variants in COL4A4 and COL4A5. Digenic Alport syndrome was subsequently diagnosed in 3 of his sisters, one of whom had previously been diagnosed with ADPKD, due to a de novo heterozygous pathogenic variant in PKD1. She had experienced an unusual clinical course for a patient with ADPKD, with remarkably rapid kidney function decline, persistent microscopic hematuria, and overt proteinuria. Through these cases, we aim to highlight alternative genetic causes of kidney cysts beyond ADPKD, describe how the phenotypical features in these cases were not fully explained by their known genotypes (leading to alternative or additional genetic diagnoses), and illustrate the importance of accurate genetic diagnoses for cascade screening.
期刊介绍:
The American Journal of Kidney Diseases (AJKD), the National Kidney Foundation's official journal, is globally recognized for its leadership in clinical nephrology content. Monthly, AJKD publishes original investigations on kidney diseases, hypertension, dialysis therapies, and kidney transplantation. Rigorous peer-review, statistical scrutiny, and a structured format characterize the publication process. Each issue includes case reports unveiling new diseases and potential therapeutic strategies.